Institute of Population Health Sciences, National Health Research Institutes, Zhunan, Miaoli County, Taiwan.
Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Oncologist. 2020 Feb;25(2):e252-e258. doi: 10.1634/theoncologist.2019-0451. Epub 2019 Nov 25.
This work examined the association between pregnancy after breast cancer (BC) diagnosis and total mortality in Taiwanese patients with BC.
The Taiwan Cancer Registry, National Health Insurance database, and Taiwan National Death Certificate database were reviewed. Patients who became pregnant after being diagnosed with BC were selected (n = 249). Four nonpregnant patients with BC were selected and matched to every pregnant patient with BC by age at diagnosis, year at diagnosis, and propensity score based on disease stage, tumor size, node involvement, and histological grade. The disease-free time interval for the selected control needed to have been longer than the time interval between the cancer diagnosis and pregnancy for the index case. Follow-up was calculated from the pregnancy date of the index case to the date of death or December 31, 2014, whichever came first. Cox proportional hazards models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs).
After adjusting for age, year at BC diagnosis, stage, positive nodes, and hormone therapy, patients with BC who became pregnant after their cancer diagnosis had lower total mortality than did the comparison group (HR = 0.44, 95% CI = 0.23-0.84), including that of estrogen receptor-positive patients (HR = 0.23, 95% CI = 0.07-0.77). The inverse association was more pronounced for those who became pregnant more than 3 years after diagnosis (HR = 0.19, 95% CI = 0.05-0.78).
Our nationwide retrospective analysis revealed that pregnancy after BC diagnosis was associated with lower mortality than that of nonpregnant patients with BC at a similar age, year at diagnosis, and clinical characteristics.
This article provides high-level evidence based on an Asian population for pregnancy counseling after a breast cancer diagnosis, including for patients with estrogen receptor-positive cancers. The study also revealed the optimal time for patients who would like to become pregnant after breast cancer.
本研究旨在探讨台湾地区乳腺癌(BC)患者诊断后妊娠与总死亡率之间的关系。
回顾了台湾癌症登记处、全民健康保险数据库和台湾国家死亡证书数据库。选择诊断为 BC 后怀孕的患者(n=249)。选择 4 名未怀孕的 BC 患者,并根据诊断时的年龄、诊断年份、疾病分期、肿瘤大小、淋巴结受累情况和组织学分级,基于倾向评分与每例怀孕的 BC 患者进行匹配。选择的对照病例的无病时间间隔需要长于指数病例的癌症诊断和妊娠之间的时间间隔。随访时间从指数病例的妊娠日期计算至死亡日期或 2014 年 12 月 31 日,以先到者为准。采用 Cox 比例风险模型估计风险比(HR)和 95%置信区间(CI)。
调整年龄、BC 诊断年份、分期、阳性淋巴结和激素治疗后,与对照组相比,诊断后怀孕的 BC 患者总死亡率较低(HR=0.44,95%CI=0.23-0.84),包括雌激素受体阳性患者(HR=0.23,95%CI=0.07-0.77)。对于诊断后 3 年以上怀孕的患者,这种反比关系更为明显(HR=0.19,95%CI=0.05-0.78)。
我们的全国性回顾性分析显示,与年龄、诊断年份和临床特征相似的未怀孕 BC 患者相比,诊断后妊娠与较低的死亡率相关。
本文为亚洲人群提供了基于高级别的证据,支持乳腺癌诊断后进行妊娠咨询,包括雌激素受体阳性癌症患者。研究还揭示了希望在乳腺癌后怀孕的患者的最佳时间。